Chronic macrolide therapy in inflammatory airways diseases
Adam L Friedlander1, Richard K Albert
1Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USA. Adam.Friedlander@UCDenver.edu
Chest
|November 6, 2010
Summary
Macrolide antibiotics, like erythromycin, offer anti-inflammatory benefits beyond their antimicrobial effects. Recent studies explore their potential to modify inflammatory airway diseases such as asthma and cystic fibrosis.
Area of Science:
- Pulmonology
- Pharmacology
- Immunology
Background:
- Long-term erythromycin therapy demonstrated efficacy in diffuse panbronchiolitis.
- Macrolides possess significant anti-inflammatory properties beyond antimicrobial activity.
Purpose of the Study:
- To review the immunomodulatory effects of macrolides.
- To assess macrolides' potential in treating inflammatory airway diseases.
Main Methods:
- Literature review of studies on macrolide immunomodulatory properties.
- Analysis of clinical trial data for macrolide use in airway diseases.
Main Results:
- Macrolides exhibit diverse immunomodulatory effects.
- Evidence suggests macrolides may be beneficial in cystic fibrosis, asthma, COPD, and bronchiolitis obliterans syndrome.
Conclusions:
- Macrolides show promise as disease-modifying agents for inflammatory airway conditions.
- Further research is warranted to fully elucidate macrolide therapeutic potential in pulmonology.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...